Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
53
LIVN Quote, Financials, Valuation and Earnings
Last price:
$68.39
Seasonality move
:
-2.11%
Day range:
$67.61 - $69.31
52-week range:
$32.48 - $69.31
Dividend yield:
0%
P/E ratio:
38.16x
P/S ratio:
2.78x
P/B ratio:
3.23x
Volume:
915.9K
Avg. volume:
662K
1-year change:
42.57%
Market cap:
$3.7B
Revenue:
$1.3B
EPS (TTM):
-$4.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
$374.6M | $1.11 | 6.94% | -20.28% | $73.00 |
|
ABT
Abbott Laboratories
|
$11.9B | $1.39 | 6.14% | 54.88% | $133.39 |
|
ATEC
Alphatec Holdings, Inc.
|
$216.3M | $0.05 | 20.01% | -91.85% | $24.62 |
|
ATRC
AtriCure, Inc.
|
$153.2M | $0.04 | 12.89% | -57.61% | $49.38 |
|
IRTC
iRhythm Holdings, Inc.
|
$218.3M | -$0.10 | 22.27% | -33.76% | $212.87 |
|
NVCR
NovoCure Ltd.
|
$170.7M | -$0.40 | -2.7% | -68.7% | $25.21 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
$68.42 | $73.00 | $3.7B | 38.16x | $0.00 | 0% | 2.78x |
|
ABT
Abbott Laboratories
|
$112.21 | $133.39 | $195.1B | 30.19x | $0.63 | 2.14% | 4.43x |
|
ATEC
Alphatec Holdings, Inc.
|
$13.01 | $24.62 | $1.9B | -- | $0.00 | 0% | 2.65x |
|
ATRC
AtriCure, Inc.
|
$32.58 | $49.38 | $1.6B | -- | $0.00 | 0% | 2.91x |
|
IRTC
iRhythm Holdings, Inc.
|
$150.96 | $212.87 | $4.9B | -- | $0.00 | 0% | 6.52x |
|
NVCR
NovoCure Ltd.
|
$11.36 | $25.21 | $1.3B | -- | $0.00 | 0% | 1.96x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
29.6% | 1.643 | 17.01% | 1.05x |
|
ABT
Abbott Laboratories
|
20.25% | 0.141 | -- | 1.12x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.400 | 27.26% | 1.21x |
|
ATRC
AtriCure, Inc.
|
13.46% | 1.617 | 3.89% | 2.88x |
|
IRTC
iRhythm Holdings, Inc.
|
82.72% | 2.239 | 12.79% | 4.44x |
|
NVCR
NovoCure Ltd.
|
70.04% | 0.751 | 55.15% | 1.44x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LIVN
LivaNova Plc
|
$244.9M | $56.6M | -12.15% | -18.29% | 15.83% | $62.2M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
ATRC
AtriCure, Inc.
|
$104.6M | $3.5M | -2.09% | -2.44% | 2.49% | $18.4M |
|
IRTC
iRhythm Holdings, Inc.
|
$148.1M | $8.8M | -5.27% | -40.07% | 4.2% | $14.5M |
|
NVCR
NovoCure Ltd.
|
$122.5M | -$36M | -16.67% | -50.08% | -21.54% | $14.9M |
LivaNova Plc vs. Competitors
-
Which has Higher Returns LIVN or ABT?
Abbott Laboratories has a net margin of 7.49% compared to LivaNova Plc's net margin of 15.5%. LivaNova Plc's return on equity of -18.29% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About LIVN or ABT?
LivaNova Plc has a consensus price target of $73.00, signalling upside risk potential of 6.69%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.88%. Given that Abbott Laboratories has higher upside potential than LivaNova Plc, analysts believe Abbott Laboratories is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 ABTAbbott Laboratories16 7 0 -
Is LIVN or ABT More Risky?
LivaNova Plc has a beta of 0.967, which suggesting that the stock is 3.292% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock LIVN or ABT?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.14% to investors and pays a quarterly dividend of $0.63 per share. LivaNova Plc pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LIVN or ABT?
LivaNova Plc quarterly revenues are $357.8M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. LivaNova Plc's net income of $26.8M is lower than Abbott Laboratories's net income of $1.8B. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while Abbott Laboratories's PE ratio is 30.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.78x versus 4.43x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.78x 38.16x $357.8M $26.8M ABTAbbott Laboratories4.43x 30.19x $11.5B $1.8B
-
Which has Higher Returns LIVN or ATEC?
Alphatec Holdings, Inc. has a net margin of 7.49% compared to LivaNova Plc's net margin of -14.54%. LivaNova Plc's return on equity of -18.29% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About LIVN or ATEC?
LivaNova Plc has a consensus price target of $73.00, signalling upside risk potential of 6.69%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 89.2%. Given that Alphatec Holdings, Inc. has higher upside potential than LivaNova Plc, analysts believe Alphatec Holdings, Inc. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is LIVN or ATEC More Risky?
LivaNova Plc has a beta of 0.967, which suggesting that the stock is 3.292% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.
-
Which is a Better Dividend Stock LIVN or ATEC?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or ATEC?
LivaNova Plc quarterly revenues are $357.8M, which are larger than Alphatec Holdings, Inc. quarterly revenues of $196.5M. LivaNova Plc's net income of $26.8M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.78x versus 2.65x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.78x 38.16x $357.8M $26.8M ATECAlphatec Holdings, Inc.2.65x -- $196.5M -$28.6M
-
Which has Higher Returns LIVN or ATRC?
AtriCure, Inc. has a net margin of 7.49% compared to LivaNova Plc's net margin of 1.25%. LivaNova Plc's return on equity of -18.29% beat AtriCure, Inc.'s return on equity of -2.44%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B ATRCAtriCure, Inc.74.43% $0.04 $568.4M -
What do Analysts Say About LIVN or ATRC?
LivaNova Plc has a consensus price target of $73.00, signalling upside risk potential of 6.69%. On the other hand AtriCure, Inc. has an analysts' consensus of $49.38 which suggests that it could grow by 49.72%. Given that AtriCure, Inc. has higher upside potential than LivaNova Plc, analysts believe AtriCure, Inc. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 ATRCAtriCure, Inc.4 2 0 -
Is LIVN or ATRC More Risky?
LivaNova Plc has a beta of 0.967, which suggesting that the stock is 3.292% less volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.415, suggesting its more volatile than the S&P 500 by 41.514%.
-
Which is a Better Dividend Stock LIVN or ATRC?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or ATRC?
LivaNova Plc quarterly revenues are $357.8M, which are larger than AtriCure, Inc. quarterly revenues of $140.5M. LivaNova Plc's net income of $26.8M is higher than AtriCure, Inc.'s net income of $1.8M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.78x versus 2.91x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.78x 38.16x $357.8M $26.8M ATRCAtriCure, Inc.2.91x -- $140.5M $1.8M
-
Which has Higher Returns LIVN or IRTC?
iRhythm Holdings, Inc. has a net margin of 7.49% compared to LivaNova Plc's net margin of 2.67%. LivaNova Plc's return on equity of -18.29% beat iRhythm Holdings, Inc.'s return on equity of -40.07%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B IRTCiRhythm Holdings, Inc.70.88% $0.17 $883.9M -
What do Analysts Say About LIVN or IRTC?
LivaNova Plc has a consensus price target of $73.00, signalling upside risk potential of 6.69%. On the other hand iRhythm Holdings, Inc. has an analysts' consensus of $212.87 which suggests that it could grow by 41.01%. Given that iRhythm Holdings, Inc. has higher upside potential than LivaNova Plc, analysts believe iRhythm Holdings, Inc. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 IRTCiRhythm Holdings, Inc.12 1 0 -
Is LIVN or IRTC More Risky?
LivaNova Plc has a beta of 0.967, which suggesting that the stock is 3.292% less volatile than S&P 500. In comparison iRhythm Holdings, Inc. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.245%.
-
Which is a Better Dividend Stock LIVN or IRTC?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iRhythm Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. iRhythm Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or IRTC?
LivaNova Plc quarterly revenues are $357.8M, which are larger than iRhythm Holdings, Inc. quarterly revenues of $208.9M. LivaNova Plc's net income of $26.8M is higher than iRhythm Holdings, Inc.'s net income of $5.6M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while iRhythm Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.78x versus 6.52x for iRhythm Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.78x 38.16x $357.8M $26.8M IRTCiRhythm Holdings, Inc.6.52x -- $208.9M $5.6M
-
Which has Higher Returns LIVN or NVCR?
NovoCure Ltd. has a net margin of 7.49% compared to LivaNova Plc's net margin of -22.29%. LivaNova Plc's return on equity of -18.29% beat NovoCure Ltd.'s return on equity of -50.08%.
Company Gross Margin Earnings Per Share Invested Capital LIVNLivaNova Plc68.44% $0.49 $1.6B NVCRNovoCure Ltd.73.25% -$0.33 $1.1B -
What do Analysts Say About LIVN or NVCR?
LivaNova Plc has a consensus price target of $73.00, signalling upside risk potential of 6.69%. On the other hand NovoCure Ltd. has an analysts' consensus of $25.21 which suggests that it could grow by 121.96%. Given that NovoCure Ltd. has higher upside potential than LivaNova Plc, analysts believe NovoCure Ltd. is more attractive than LivaNova Plc.
Company Buy Ratings Hold Ratings Sell Ratings LIVNLivaNova Plc6 2 0 NVCRNovoCure Ltd.4 2 0 -
Is LIVN or NVCR More Risky?
LivaNova Plc has a beta of 0.967, which suggesting that the stock is 3.292% less volatile than S&P 500. In comparison NovoCure Ltd. has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.187%.
-
Which is a Better Dividend Stock LIVN or NVCR?
LivaNova Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovoCure Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LivaNova Plc pays -- of its earnings as a dividend. NovoCure Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LIVN or NVCR?
LivaNova Plc quarterly revenues are $357.8M, which are larger than NovoCure Ltd. quarterly revenues of $167.2M. LivaNova Plc's net income of $26.8M is higher than NovoCure Ltd.'s net income of -$37.3M. Notably, LivaNova Plc's price-to-earnings ratio is 38.16x while NovoCure Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LivaNova Plc is 2.78x versus 1.96x for NovoCure Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LIVNLivaNova Plc2.78x 38.16x $357.8M $26.8M NVCRNovoCure Ltd.1.96x -- $167.2M -$37.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
